Skip to content

Optimal effective volume of lidocaine for experimental infraorbital nerve block

Optimal effective volume of lidocaine for experimental infraorbital nerve block

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105596
Enrollment
Unknown
Registered
2025-07-07
Start date
2024-11-12
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigeminal neuralgia

Interventions

experimental group:Dose of local anesthetic for infraorbital nerve block

Sponsors

Pain Department of Nanjing Drum Tower Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Patients with pain in the second branch of the trigeminal nerve; (2) The patient agrees to sign the informed consent form; (3) The age of the patient is 20 - 85 years old; (4) American Society of Anesthesiologists ASA classification Class I – III; (5) Body mass index of 20 - 35 kg/m^2.

Exclusion criteria

Exclusion criteria: (1) The patient's coagulation is abnormal; (2) the patient refuses to undergo block therapy; (3) the patient is allergic to lidocaine; (4)Patient with liver and kidney failure; (5) The patient has a rupture of the cheek and face; (6) The patient has abnormal mental illness and cannot cooperate.

Design outcomes

Primary

MeasureTime frame
Sensation (cold, tactile);

Secondary

MeasureTime frame
visual analogue scale, VAS;

Countries

China

Contacts

Public ContactGaojian Tao

Pain Department of Nanjing Drum Tower Hospital

13851824697@163.com+86 138 5182 4697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026